It's sad to have to wait for death to close off studies isn't it. I.e. the OS outcomes. Being late stage and non responsive to other treatments is drawing a short straw in life, to then be in a trial on SOC only where the trialled drug (hopefully soon to be marketable product) is providing statistically significant efficacy and benefit in the other arm is drawing an even shorter straw. Something I'm trying to comprehend. It's bizarre really.
Anyway onwards and upwards and I really am looking forward to updates for all patients on the B Cell therapies to date both HerVaxx and PD1-VAXX.
Ann: Investor Presentation, page-77
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |